Insider · CIK 0001437782

Oliveto Joseph

Reports to the SEC for 2 companies · MONTREAL

sec.gov

Transactions

Companies

Filings

CIK

0001437782

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-16	MISTMilestone Pharmaceuticals Inc.S Sale	Director, President and CEO	SSale	−36.5K sh	$2.26	−$82.5K	446,244
2026-02-02	MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+679K sh	—	—	679,000
2026-02-02	MISTMilestone Pharmaceuticals Inc. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+453K sh	—	—	453,000
2026-02-02	MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+679K sh	—	—	679,000
2026-01-26	MISTMilestone Pharmaceuticals Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+66.6K sh	—	—	517,267
2026-01-26	MISTMilestone Pharmaceuticals Inc.S Sale	Director, President and CEO	SSale	−34.5K sh	$1.93	−$66.6K	482,744
2026-01-26	MISTMilestone Pharmaceuticals Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−66.6K sh	—	—	199,800
2026-01-08	MISTMilestone Pharmaceuticals Inc.S Sale	Director, President and CEO	SSale	−43K sh	$2.25	−$96.8K	303,721
2026-01-07	MISTMilestone Pharmaceuticals Inc.S Sale	Director, President and CEO	SSale	−500 sh	$2.25	−$1,125	346,721
2025-12-15	MISTMilestone Pharmaceuticals Inc.S Sale	Director, President and CEO	SSale	−133K sh	$2.32	−$309K	450,667
2025-12-12	MISTMilestone Pharmaceuticals Inc.A Award	Director, President and CEO	AAward	+280K sh	—	—	583,721
2025-12-12	MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+280K sh	—	—	280,000
2025-07-11	MISTMilestone Pharmaceuticals Inc.A Award	Director, President and CEO	AAward	+66.7K sh	—	—	347,221
2025-07-11	MISTMilestone Pharmaceuticals Inc. · Series A Common Warrants (right to buy)A Award	Director, President and CEO	AAward	+66.7K sh	—	—	66,666
2025-07-11	MISTMilestone Pharmaceuticals Inc. · Series B Common Warrants (right to buy)A Award	Director, President and CEO	AAward	+66.7K sh	—	—	66,666
2025-01-27	MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+400K sh	—	—	399,600
2025-01-27	MISTMilestone Pharmaceuticals Inc. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+266K sh	—	—	266,400
2023-02-16	MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+360K sh	—	—	360,000
2022-03-21	MISTMilestone Pharmaceuticals Inc. · Employee Stock Option Grant (right to buy)A Award	Director, President and CEO	AAward	+500K sh	—	—	500,000
2021-03-24	MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+670K sh	—	—	670,000
2020-06-05	MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+150K sh	—	—	150,000
2020-01-23	MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+200K sh	—	—	200,000
2019-12-21	MISTMilestone Pharmaceuticals Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,400 sh	$1.54	+$11.4K	280,555
2019-12-21	MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,400 sh	—	—	113,856
2014-01-22	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+150K sh	—	—	150,000
2013-01-07	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+150K sh	—	—	150,000
2012-07-09	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+150K sh	—	—	150,000
2012-01-25	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+50K sh	—	—	50,000
2011-01-11	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+50K sh	—	—	50,000
2010-08-12	Chelsea Therapeutics International, Ltd.P Purchase	Director, President and CEO	PPurchase	+3,500 sh	$2.87	+$10K	3,500
2010-01-19	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+50K sh	—	—	50,000
2009-01-22	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Apr 204
Oliveto Joseph0001437782-26-000010
SEC(opens sec.gov)
Feb 54/A
Oliveto Joseph0001437782-26-000007
SEC(opens sec.gov)
Feb 44
Oliveto Joseph0001437782-26-000006
SEC(opens sec.gov)
Jan 284
Oliveto Joseph0001437782-26-000004
SEC(opens sec.gov)
Jan 94
Oliveto Joseph0001437782-26-000002
SEC(opens sec.gov)
Jul 154
Oliveto Joseph0001415889-25-019772
SEC(opens sec.gov)
Jan 294
Oliveto Joseph0001415889-25-002265
SEC(opens sec.gov)
Feb 174
Oliveto Joseph0001209191-23-010697
SEC(opens sec.gov)
Mar 234
Oliveto Joseph0001209191-22-020840
SEC(opens sec.gov)
Mar 264
Oliveto Joseph0001209191-21-023353
SEC(opens sec.gov)

Companies

Address

C/O MILESTONE PHARMACEUTICALS INC. 1111 DR. FREDERIK-PHILIPS BLVD, STE 420

MONTREAL, H4M 2X6